Moreover, a murine orthotopic xenograft model of PDAC with PANC-1 cells revealed that the pharmacological ALK5 kinase inhibitor, SD-208 (59), reduced primary tumor weight and decreased the incidence of metastasis. The gene discussed is TGFBR1; the disease is neoplasm.